These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6605391)

  • 41. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells.
    Lee LS; Weinstein IB
    Nature; 1978 Aug; 274(5672):696-7. PubMed ID: 307695
    [No Abstract]   [Full Text] [Related]  

  • 43. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
    Laug WE
    Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM; Dewerchin M; Lijnen HR; Bernar H; Bulens F; Nelles L; Collen D
    Eur J Biochem; 1992 Apr; 205(1):139-46. PubMed ID: 1313361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells.
    Loskutoff DJ; Mussoni L
    Blood; 1983 Jul; 62(1):62-8. PubMed ID: 6683113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.
    Laiho M; Saksela O; Keski-Oja J
    Exp Cell Res; 1986 Jun; 164(2):399-407. PubMed ID: 3519251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynold LM
    Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor and 12-tetradecanoyl phorbol 13-acetate induction of urokinase in A431 cells.
    Kessler TL; Markus G
    Semin Thromb Hemost; 1991 Jul; 17(3):217-24. PubMed ID: 1796295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cells.
    Hettle JA; Waller EK; Fritz IB
    Biol Reprod; 1986 Jun; 34(5):895-904. PubMed ID: 3730484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells.
    Fukushima M; Nakashima Y; Sueishi K
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1576-83. PubMed ID: 2501229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasminogen activator secreted by cultured human melanocytes.
    Hashimoto K; Horikoshi T; Nishioka K; Yoshikawa K; Carter DM
    Br J Dermatol; 1986 Aug; 115(2):205-9. PubMed ID: 3091061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors.
    Saksela O; Laiho M; Keski-Oja J
    Cancer Res; 1985 May; 45(5):2314-9. PubMed ID: 3921241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasminogen activator activity in the bovine oocyte-cumulus complex and early embryo.
    Yamada M; Horiuchi T; Oribe T; Yamamoto S; Matsushita H; Gentry PA
    J Vet Med Sci; 1996 Apr; 58(4):317-22. PubMed ID: 8741263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in basal cell subpopulations and tissue differentiation in human epidermal cultures treated with epidermal growth factor and cholera toxin.
    Jensen PK; Nørgård JO; Bolund L
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(4):325-40. PubMed ID: 2417407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
    Kole KL; Gyetko MR; Simpson RU; Sitrin RG
    Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.